Hugh Auchincloss (immunologist)

Last updated
Laurie Glimcher
​
​
(m. 1973,divorced)​
Hugh Auchincloss
Hugh Auchincloss.jpg
Director of the National Institute of Allergy and Infectious Diseases
Acting
1 January 2023 –24 September 2023
Children3, including Jake
Education Yale University (BA, MA)
Harvard University (MD)

Hugh Auchincloss, Jr. (pronounced: aa-kuhn-klaas; born March 15, 1949) is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022. He was previously a transplant surgeon and professor of surgery at Harvard Medical School, and researched at Massachusetts General Hospital for 17 years.

Contents

Early life and education

Hugh Auchincloss, Jr., was born in New York City on March 15, 1949 [1] to Hugh Auchincloss, Sr. (1915−1998), and Katharine Lawrence Bundy. His mother was the daughter of lawyer Harvey Hollister Bundy, and the granddaughter of banker William Lowell Putnam. Auchincloss, Sr., was a long-time surgeon at Columbia University and The Valley Hospital. [2] His father is the first cousin once-removed of stockbroker Hugh D. Auchincloss. [3]

Auchincloss graduated from Groton School. [4] At Yale University, he completed an A.B. magna cum laude in political science and economics in 1972, and a master's degree in economics. [4] [5] Auchincloss graduated with Phi Beta Kappa honors. He completed his M.D. from Harvard Medical School in 1976. [5]

Career

Auchincloss was a transplant surgeon and professor of surgery at Harvard Medical School. For more than 17 years he operated a laboratory in transplantation immunology at Massachusetts General Hospital. In 1998, he founded the Juvenile Diabetes Research Foundation Center for Islet Transplantation and served as its director until 2003. He subsequently served as chief operating officer of the NIAID Immune Tolerance Network. [5] [6]

In 2006, he joined the National Institute of Allergy and Infectious Diseases (NIAID) as the principal deputy director. [6] He led the development of the Institute's strategic plan and chaired the NIAID Research Initiative Committee, an internal governance group that has designed and implemented a more efficient approach to planning, developing, and approving NIAID initiatives. Auchincloss is oversees an NIAID initiative to design and implement changes in the Institute's clinical research infrastructure, which will be flexible and available for domestic and international clinical research on HIV/AIDS and other infectious diseases. Auchincloss is part of an NIAID senior leadership group responsible for reviewing all aspects of HIV/AIDS research policy, including the evaluation of “test and treat” strategies, analysis of results of pre-exposure prophylaxis (PrEP) clinical trials (including microbicide trials), and coordination of future HIV/AIDS vaccine clinical trials. [5]

In 2005, Auchincloss was elected president of the American Society of Transplantation. He has authored scientific articles and texts and serves on the editorial boards of scientific publications. [6] Auchincloss is on federal and NIH-wide committees, including the Trans-Federal Task Force on Optimizing Biocontainment Oversight, the National Security Strategy/Office of Science and Technology Policy on Optimizing Biological Select Agents and Toxins Working Group, and the National Biodefense Science Board. He was appointed as co-chair of the International Clinical Research Subcommittee of the NIH Global Health Research Working Group and as a member of the NIH Institute and Center Directors Clinical and Translational Science Awards Advisory Board. He also serves as the NIH point of contact for the Emergency Use Authorization program. [5]

In January 2023, Auchincloss succeeded Anthony Fauci as the acting NIAID director. [7]

Personal life

On August 26, 1973, Auchincloss married Laurie Glimcher, a fellow Harvard Medical School student, at the Memorial Church of Harvard University. [4] Before their divorce, they had 3 children including politician Jake Auchincloss. [8] [9]

Related Research Articles

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<span class="mw-page-title-main">Anthony Fauci</span> American immunologist (born 1940)

Anthony Stephen Fauci is an American physician-scientist and immunologist who served as the director of the National Institute of Allergy and Infectious Diseases (NIAID) from 1984 to 2022, and the chief medical advisor to the president from 2021 to 2022. Fauci was one of the world's most frequently cited scientists across all scientific journals from 1983 to 2002. In 2008, President George W. Bush awarded him the Presidential Medal of Freedom, the highest civilian award in the United States, for his work on the AIDS relief program PEPFAR.

VaxGen was a biopharmaceutical company based in the San Francisco Bay Area.

<span class="mw-page-title-main">AIDS Clinical Trials Group</span>

The AIDS Clinical Trials Group network (ACTG) is one of the largest HIV clinical trials organizations in the world, playing a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV and AIDS in the United States and the developing world. The ACTG is composed of, and directed by, leading clinical scientists in HIV/AIDS therapeutic research. The ACTG is funded by the Department of Health and Human Services, National Institutes of Health through the National Institute of Allergy and Infectious Diseases.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.

<span class="mw-page-title-main">Jeffrey P. Nadler</span> American physician

Jeffrey P. Nadler is an American Infectious Diseases and HIV/AIDS expert. His most recent position has been as Acting Director and Assistant Director of the Therapeutics Research Program, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID) where he oversaw NIH/NIAID-sponsored national and international HIV/AIDS research.

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.

<span class="mw-page-title-main">Stephen C. Harrison</span> American chemist and pharmacologist

Stephen C. Harrison is professor of biological chemistry and molecular pharmacology, professor of pediatrics, and director of the Center for Molecular and Cellular Dynamics of Harvard Medical School, head of the Laboratory of Molecular Medicine at Boston Children's Hospital, and investigator of the Howard Hughes Medical Institute.

<span class="mw-page-title-main">Lauren V. Wood</span> American allergist, immunologist

Lauren V. Wood is an American allergist, immunologist, and staff physician at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she has served as a principal investigator. She is known for conducting studies of vaccines for cancer, Human papillomavirus (HPV), Hepatitis C, and HIV especially for use with children, teens and young adults. She holds the rank of captain in the U.S. Public Health Service (PHS).

Thomas Charles Merigan was born January 18, 1934 in San Francisco. He is an American virologist and the George E. and Lucy Becker Professor of Medicine, Emeritus at the Stanford University School of Medicine. Merigan's research first focused on human viral pathogenesis, basic and clinical studies of interferon, and then developing the first systemically active antiviral drugs including those effectively treatIng HIV/AIDS, several herpesviruses and hepatitis B. He is also credited with helping to develop the use of interferons as antiviral, immunomodulating and antitumor therapies. Merigan joined the Stanford faculty in 1963 and assumed full emeritus status in 2007. In 2004 he was also identified as one of the 250 most cited investigators in clinical medicine over the last 20 years by the Institute for Scientific Information. Merigan also was ranked 23rd among the 1000 top US microbiologists by Research.com in 2022. His papers have been cited over 45,000 times. He had over 95 postdoctoral fellows, students and visiting scientists with whom he published 577 papers, 24 books, monographs and published symposia, and held 11 US patents. Two of his books went into multiple editions- one into a 4th edition and the other into a 3rd. His students have become leaders in the fields of infectious diseases and microbiology both in the US and rest of the world. Seven of his students subsequently joined the fulltime Stanford medical faculty. He was a board member of 28 journals and a member of 23 learned societies. He told his life story in a book entitled Pioneering Viral Therapy,a Life in Academic Medicine, published by Amazon/Kindle/CreateSpace in 2017.

<span class="mw-page-title-main">Robert T. Schooley</span> American infectious disease physician

Robert "Chip" T. Schooley is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection.

<span class="mw-page-title-main">Emily Erbelding</span> American physician and scientist

Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.

<span class="mw-page-title-main">Irini Sereti</span> Greek scientist and physician

Irini Sereti is a Greek scientist and physician. She is chief of the HIV pathogenesis section at the National Institute of Allergy and Infectious Diseases. Sereti researches immune reconstitution inflammatory syndrome, idiopathic CD4 lymphocytopenia, and immune-based therapeutic strategies of HIV investigation.

<span class="mw-page-title-main">Jake Auchincloss</span> American politician (born 1988)

Jacob Daniel Auchincloss is an American politician, businessman, and Marine veteran serving as the U.S. representative for Massachusetts's 4th congressional district since 2021. He is a member of the Democratic Party.

<span class="mw-page-title-main">Jeanne Marrazzo</span> American microbiologist

Jeanne Marisa Marrazzo is an American physician-scientist and infectious diseases specialist. She was the director of the University of Alabama School of Medicine Division of Infectious Diseases and focused on prevention of HIV infection using biomedical interventions. Marrazzo is a fellow of the American College of Physicians and Infectious Disease Society of America. On August 2, 2023 Lawrence A. Tabak, acting director for the National Institutes of Health (NIH), named Jeanne M. Marrazzo as director of NIH’s National Institute of Allergy and Infectious Diseases.

Kimberly Y. Smith is an American scientific executive and medical doctor serving as the head of research and development at ViiV Healthcare.

<span class="mw-page-title-main">John La Montagne</span> Mexican-American biomedical scientist (1943–2004)

John Ring La Montagne was a Mexican-American biomedical scientist who served as the deputy director of the National Institute of Allergy and Infectious Diseases from 1998 to 2004. He specialized in viral vaccines, HIV/AIDS research, and oversaw NIH's biodefense research after the September 11 attacks.

<span class="mw-page-title-main">Hilary D. Marston</span> American physician-scientist and policy advisor

Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.

<span class="mw-page-title-main">John R. Mascola</span> American Physician-Scientist

John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.

References

  1. 1 2 Office of NIH History & Stetten Museum (November 28, 2022). "Dr. Hugh Auchincloss Oral History". National Institutes of Health. Retrieved October 7, 2023.
  2. ↑ "Hugh Auchincloss, Surgeon, Dies at 83 (Published 1998)". The New York Times. 1998-10-31. ISSN   0362-4331 . Retrieved 2021-01-18.
  3. ↑ "Auchincloss wins primary in Massachusetts' 4th District". Roll Call. 4 September 2020. Retrieved 2021-01-18.
  4. 1 2 3 "Laurie Hollis Glimcher, Hugh Auchincloss Jr. wed". The Boston Globe. 1973-09-09. p. 69. Retrieved 2021-01-18– via Newspapers.com.
  5. 1 2 3 4 5 "Hugh Auchincloss, M.D." www.niaid.nih.gov. 9 May 2018. Retrieved 2021-01-18.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  6. 1 2 3 "NIAID Announces Five Appointments" (PDF). NIH Record . 2006-03-10. Retrieved 2021-01-18.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  7. ↑ Baumann, Jeannie (December 9, 2022). "Fauci's Longtime No. 2 Tapped to Head Infectious Disease Center". Bloomberg Law. Retrieved 2023-01-05.
  8. ↑ "In 4th District race, Jake Auchincloss stands out — for the flack he gets | Boston.com". www.boston.com. Retrieved 2021-01-18.
  9. ↑ Powell, Alvin (2006-11-02). "Glimchers are unusual father-daughter duo". Harvard Gazette. Retrieved 2021-01-18.
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.
Government offices
Preceded by Director of the National Institute of Allergy and Infectious Diseases
Acting
2023-present		Incumbent
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.